Results 31 to 40 of about 36,987 (240)

COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges

open access: yesThe Pan African Medical Journal, 2020
With the major spread of SARS-COV-2 around the world, its association with various pathologies has been reported. However, hemopathy has rarely been revealed during a coronavirus infection.
Boubaker Charra   +7 more
doaj   +1 more source

Fitness in CLL

open access: yesCancers
The increased complexity of CLL management, driven by the advent of targeted therapies, makes it necessary to redefine the concept of fitness, which until a few years ago was limited to the patient’s ability to undergo chemoimmunotherapy. In the current therapeutic landscape, fitness assessment must also consider biological age, comorbidities, and ...
Claudia Baratè   +9 more
openaire   +4 more sources

repDilPCR: a tool for automated analysis of qPCR assays by the dilution-replicate method

open access: yesBMC Bioinformatics
Background The dilution-replicate experimental design for qPCR assays is especially efficient. It is based on multiple linear regression of multiple 3-point standard curves that are derived from the experimental samples themselves and thus obviates the ...
Deyan Yordanov Yosifov   +3 more
doaj   +1 more source

The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical View

open access: yesJournal of Experimental Pharmacology, 2021
Francesco Paolo Tambaro,1 Danilo De Novellis,1,2 William G Wierda3 1Unità Operativa di Trapianto di Midollo Osseo e Servizio Trasfusionale, Azienda Ospedaliera di Rilievo Nazionale Santobono-Pausilipon, Napoli, Italy; 2Department of Precision Medicine ...
Tambaro FP, De Novellis D, Wierda WG
doaj  

sj-docx-1-cll-10.1177_09636897221104452 – Supplemental material for Endometrial Cancer-Infiltrating Mesenchymal Stem Cells Exhibit Immunosuppressive Effects

open access: yes, 2022
Supplemental material, sj-docx-1-cll-10.1177_09636897221104452 for Endometrial Cancer-Infiltrating Mesenchymal Stem Cells Exhibit Immunosuppressive Effects by Kai-Hung Wang, Yu-Hsun Chang, Tomor Harnod and Dah-Ching Ding in Cell ...
Tomor Harnod (3836590)   +3 more
core   +1 more source

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL [PDF]

open access: yesBlood, 2017
Key Points Pembrolizumab was first shown to be clinically active in CLL patients with RT. PD-1 and PD-L1 expression in tumor microenvironment are promising biomarkers to select RT patients for PD-1 blockade.
Wei, Ding   +34 more
openaire   +2 more sources

Using cell‐free RNA to identify B‐ and T‐cell clonality for diagnosis and monitoring of B‐ and T‐cell neoplasms

open access: yesFEBS Open Bio, EarlyView.
Using peripheral blood for determining B‐cell or T‐cell clonality is more reliable when we use cell‐free RNA (cfRNA) because cells release blood significantly more RNA than DNA. Next‐generation sequencing (NGS) of cfRNA allows us to evaluate fragment cfRNA and evaluate clonality reliably without the need for prior determination of the specific dominant
Adam Albitar   +11 more
wiley   +1 more source

Genotyping from targeted NGS data based on a small set of SNPs correctly matches patient samples

open access: yesBMC Research Notes
Objective Mislabelling and swapping of laboratory samples are handling errors that can lead to erroneous interpretation of data and/or patient harm.
Deyan Yordanov Yosifov   +4 more
doaj   +1 more source

sj-jpg-2-cll-10.1177_09636897231173736 – Supplemental material for Exosomes From Adipose-Derived Stem Cells Suppress the Progression of Chronic Endometritis

open access: yes, 2023
Supplemental material, sj-jpg-2-cll-10.1177_09636897231173736 for Exosomes From Adipose-Derived Stem Cells Suppress the Progression of Chronic Endometritis by Bin Wang, Li Li and Ruizhu Yu in Cell ...
Ruizhu Yu (15524156)   +2 more
core   +1 more source

GBS‐MeDIP: A method for the simultaneous identification of genetic and epigenetic variants in tumors

open access: yesFEBS Open Bio, EarlyView.
GBS‐MeDIP combines DNA sequencing with enrichment of methylated DNA to profile genetic and epigenetic variation in the same reduced genomic fraction. Applied to gastric cancer and parathyroid tumors, it identifies sequence variants, copy number changes, and differentially methylated regions together, helping distinguish true epigenetic changes from ...
Fábio Pértille   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy